SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Domestic pharma firms likely to post 7-9% revenue growth in FY26: Icra

19 Sep 2025 Evaluate

Rating firm Icra has said that revenue of leading domestic pharmaceutical companies is set to expand by 7-9 per cent in the current fiscal (FY26) even as global headwinds and regulatory uncertainties cast a shadow over its largest export market, the US. It mentioned revenue for the sample set of companies is projected to expand by 7-9 per cent in FY26, supported by 8-10 per cent growth in the domestic market and 10-12 per cent growth in Europe. 

However, it stated performance in the US market is expected to moderate, with year-on-year growth slowing to 3-5 per cent, from nearly 10 per cent in FY25. The operating profit margins (OPM) of ICRA's sample entities are expected to remain resilient at 24-25 per cent in FY26, broadly in line with 24.6 per cent in FY25, aided by favourable raw material prices, improved operating leverage, and a rising share of speciality products.

Research and Development (R&D) spending is projected to remain steady at 6-7 per cent of revenues, with companies increasingly focusing on complex molecules and speciality products over generics. Icra said it estimates total capital expenditure for its sample set to reach Rs 42,000-45,000 crore in FY26, including Rs 25,000 crore in inorganic investments.


About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×